Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Latin Metals grants Aumin option to acquire Organullo gold project for US$4 million

Latin Metals grants Aumin option to acquire Organullo gold project for US$4 million

BitgetBitget2026/09/21 16:06
  • Latin Metals granted Aumin an option to acquire 100% of the Organullo Gold Project in Salta Province, Argentina.
  • Transaction terms include US$ 4 million in cash payments to Latin Metals over six years.
  • Aumin committed to 40,000 meters of drilling over six years, with 3,000 meters due by year one.
  • On exercise, Latin Metals can choose 19.9% of a listed vehicle or a 2% net smelter returns royalty.
  • Aumin can accelerate after 15,000 meters by paying remaining cash plus US$ 16 million; Latin Metals would retain a 2% NSR royalty.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Latin Metals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609210830PRIMZONECNPR____9829884) on September 21, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11

SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.

The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).

智通财经2026/09/22 07:11